Pascal Soriot Britain city Oxford vaccine Volunteers Coronavirus Pascal Soriot Britain city Oxford

Oxford coronavirus vaccine trial 'to resume in days' after pause over volunteer illness

Reading now: 530
www.mirror.co.uk

The trial of an Oxford coronavirus vaccine tipped to be the frontrunner in the fight against the pandemic could resume within days after it was halted.

AstraZeneca Plc - which is working alongside the University of Oxford - has confirmed it had had to pause development of the vaccine "to allow review of safety data".

It is believed a British volunteer suffered an adverse reaction during the trial. Health industry website Stat, who first reported the vaccine pause, said the woman was on course to be discharged from hospital as early as last night.

It was described as a "temporary pause" by Pascal Soriot, the chief executive of Astrazeneca. An AstraZeneca spokesperson described the pause as a "routine action" which must happen whenever a

Read more on mirror.co.uk
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA